Balentine LLC’s Sabra Healthcare REIT SBRA Stock Holding History

Balentine LLC’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-57	Closed	-$1K	–	435
2017 Q4	$1K	Hold	57	–	–	﹤0.01%	620
2017 Q3	$1K	Buy	+57	New	+$1.29K	﹤0.01%	634

Other funds holding SBRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAMU

APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Balentine LLC's SBRA Position: Q1 2018 in Review

Balentine LLC sold out of Sabra Healthcare REIT (SBRA) in Q1 2018, closing a stake of 57 shares — an estimated $1K sold.

Balentine LLC first reported a position in SBRA in Q3 2017 and held it in 2 quarters. The position peaked at $1K in Q4 2017. 327 funds tracked by Wall St. Rank hold SBRA as of Q1 2018.

Balentine LLC reported no remaining Sabra Healthcare REIT position as of Q1 2018 after selling out during the quarter.
Balentine LLC sold 57 Sabra Healthcare REIT shares in Q1 2018, an estimated $1K.
Balentine LLC first reported a position in Sabra Healthcare REIT in Q3 2017 and held it in 2 quarters.
Balentine LLC's Sabra Healthcare REIT position peaked at $1K in Q4 2017.
327 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2018.

Based on Balentine LLC's 13F filing for Q1 2018, filed 16 May 2018.